hit counter
CASI Pharmaceuticals, Inc. (CASI) Stock News Sentiment & Price - Sentifly
CASI - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



CASI Pharmaceuticals, Inc. (CASI)

USA
Biotechnology
NASDAQ
CASI Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
CASI Latest news
Zacks Investment Research
Negative
CASI Pharma (CASI) Sees Hammer Chart Pattern: Time to Buy?
2021-10-06 10:30

CASI Pharma (CASI) has been struggling lately, but the selling pressure may be coming to an end soon.

PennyStocks
Positive
Penny Stocks For Your Biotech Watch List In September 2021
2021-09-15 11:04

Penny stocks that may be worth watching right now. The post Penny Stocks For Your Biotech Watch List In September 2021 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Benzinga
Positive
4 Penny Stocks Insiders Are Buying
2021-08-23 09:58

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

PennyStocks
Positive
Trending Penny Stocks To Buy For Under $3 Right Now
2021-08-23 09:29

Are these penny stocks worth the risk? The post Trending Penny Stocks To Buy For Under $3 Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Pulse2
Positive
CASI Pharmaceuticals Shares Increase Over 15% Pre-Market: Why It Happened
2021-08-23 06:23

The shares of CASI Pharmaceuticals, Inc. (Nasdaq: CASI) increased by over 16% pre-market. This is why it happened.

Seeking Alpha
Neutral
CASI Pharmaceuticals, Inc. (CASI) CEO Dr. Wei-Wu He on Q2 2021 Results - Earnings Call Transcript
2021-08-13 11:59

CASI Pharmaceuticals, Inc. (CASI) CEO Dr. Wei-Wu He on Q2 2021 Results - Earnings Call Transcript

Zacks Investment Research
Positive
CASI Pharmaceuticals, Inc. (CASI) Reports Q2 Loss, Tops Revenue Estimates
2021-08-12 11:40

CASI Pharmaceuticals, Inc. (CASI) delivered earnings and revenue surprises of 44.44% and 16.46%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

PRNewsWire
Neutral
CASI Pharmaceuticals To Report Second Quarter 2021 Financial Results And Host Conference Call August 12, 2021
2021-08-10 07:00

ROCKVILLE, Md. and BEIJING, Aug. 10, 2021 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today announced the Company will host a conference call reviewing the second quarter highlights at 8:00 a.m.

Zacks Investment Research
Negative
Analysts Estimate CASI Pharmaceuticals, Inc. (CASI) to Report a Decline in Earnings: What to Look Out for
2021-08-02 16:46

CASI Pharmaceuticals, Inc. (CASI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Loading more news...